Related Experiment Video
Updated: Aug 6, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Selpercatinib-Induced Deep Skin Fissures Triggered by Mechanical Friction in a Patient With RET Fusion-Positive Lung
Tomoyuki Ikeuchi1, Mitsuhiro Yamamoto1, Hirokazu Toge1
1Department of Respiratory Medicine National Hospital Organization (NHO) Yonago Medical Center Yonago Japan.
Abstract:
We report a case of selpercatinib-induced deep skin fissures in a patient with RET fusion-positive lung adenocarcinoma. Minor mechanical abrasions triggered severe fingertip fissures, which were likely exacerbated by selpercatinib-related VEGF receptor inhibition. The condition improved with drug withdrawal and corticosteroids administration, enabling the continuation of treatment with careful management of recurrent episodes.
Insights
Selpercatinib can cause severe fingertip fissures in patients with RET fusion-positive lung adenocarcinoma. Stopping the drug and using corticosteroids improved the skin condition, allowing treatment to continue.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Selpercatinib is a targeted therapy for RET fusion-positive lung adenocarcinoma.
- VEGF receptor inhibition is a known mechanism of action for selpercatinib.
- Skin toxicities are potential side effects of targeted cancer therapies.
Purpose of the Study:
- To report a case of deep skin fissures induced by selpercatinib.
- To explore the potential mechanism of selpercatinib-induced skin fissures.
- To describe the management and outcome of this adverse event.
Main Methods:
- Case report of a patient with RET fusion-positive lung adenocarcinoma.
- Observation of selpercatinib-induced fingertip fissures.
- Assessment of treatment response to drug withdrawal and corticosteroid administration.
Main Results:
- A patient developed severe fingertip fissures after starting selpercatinib.
- Fissures were triggered by minor abrasions and potentially worsened by VEGF receptor inhibition.
- Discontinuation of selpercatinib and administration of corticosteroids led to improvement.
Conclusions:
- Selpercatinib can cause significant skin toxicity, specifically deep fissures.
- VEGF receptor inhibition may play a role in the pathogenesis of these fissures.
- Management involves drug withdrawal, corticosteroids, and careful monitoring for recurrence.